|
Research Priorities:
Our collaboration with Shiraz University of Medical Sciences (SUMS) focuses on advancing stem cell therapy, particularly mesenchymal stem cells (MSCs) and exosome therapy, for various diseases. We aim to exchange PhD and postdoc students, conduct collaborative projects, and potentially commercialize therapies.
Stem Cell Research Focus: MSCs and Exosome Therapy
MSCs, multipotent cells with immune-modulating properties, hold promise for regenerative medicine. Our priorities include developing MSC isolation protocols, studying their differentiation potential, and exploring their immunomodulatory effects. We also aim to investigate the therapeutic potential of MSC-derived exosomes, focusing on their isolation, characterization, and mechanisms of action in tissue repair and immunomodulation.
We propose a student exchange program to enhance collaboration. Students will receive training in stem cell and exosome research, participate in joint projects, and benefit from mentorship and networking opportunities.
Our joint projects will focus on disease modeling, clinical trials, and biomarker discovery. We aim to develop disease models, conduct preclinical and clinical trials, and identify biomarkers for monitoring treatment response.
To translate our research into therapies, we plan to protect intellectual property, form industry partnerships, and support startup creation. This will ensure the commercial viability of MSC and exosome-based therapies.
|